Grants are how most health-tech startups in Africa get their first proof of concept. They are also, almost universally, how those same startups run out of runway — because a grant cycle is built to fund a pilot, not a company. The founders who make it through that gap usually do it with a different kind of backer: the philanthropic angel.
What a philanthropic angel
actually is
A philanthropic angel sits between a traditional donor and a traditional investor. They write a check the way an angel investor does — early, personally, with real risk tolerance — but they underwrite it the way a philanthropist does: against impact evidence, not just a pitch deck. They’re often individuals or small family vehicles who have already made their capital in another industry entirely, and who now want that capital to do two things at once: return something, and mean something.
This is a different profile than an institutional grants officer or a VC associate. They move faster, ask sharper questions about outcomes rather than TAM slides, and they’re comfortable being the first check into something that hasn’t fully de-risked yet — which is exactly the stage most LMIC health-tech companies are stuck at.
Where Navigacare sits right now
Navigacare is a patient journey coordination platform live and ready for pilots in hospitals across Nigeria, built solo from the ground up and carries a C/Can accreditation for cancer-care coordination. The product works. The early AI simulated deployments work. What the company needs next is a pilot grant and runway: the capital to take a working system to a handful of hospitals and to a network, without the twelve-month funding gaps that kill momentum between grant cycles.
What runway capital looks like for a company at this stage
- Bridge / pre-seed extension: capital that keeps a working product moving between larger institutional rounds
- SAFE-structured checks: simple, fast, founder-friendly instruments that don’t require a full priced round
- Grant-plus-equity blends: philanthropic grant funding for outcome validation, paired with a small equity or convertible check for growth capital
- 12–24 month horizon: enough runway to convert current traction into the metrics a larger institutional or catalytic investor will want to see
Why this moment matters
Every health-tech company in a low-resource market hits the same wall: too proven for a grant, too early for a fund. Philanthropic angels and runway-stage backers are the ones who actually close that gap — not because it’s easy money, but because they’re underwriting conviction in a founder and a problem, not just a spreadsheet.
If that’s the kind of check you write, Navigacare is at exactly the stage where it matters most.
Learn more or start a conversation: navigacare.online
Navigacare is a patient journey coordination platform for hospitals in low- and middle-income countries, built and operated by Planetbridge Nigeria Limited and WhiteRock Innovations Ltd.
Leave a Reply